These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 353599)

  • 41. Sensitivity of strains of enteropathogenic Escherichia coli to tobramycin and other antibiotics.
    Konforti N; Lev B; Hanner N
    Med Microbiol Immunol; 1977 Dec; 163(4):269-76. PubMed ID: 342889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New aminoglycoside antibiotics].
    Dzierzanowska D
    Pol Tyg Lek; 1977 Sep; 32(38):1483-6. PubMed ID: 905200
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antibiotic sensitivity of enteropathogenic strains of Escherichia coli isolated from children with diarrhea].
    Ruczkowska J; Gościniak G; Dolna I
    Przegl Epidemiol; 1990; 44(3):199-201. PubMed ID: 2084803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative studies on activities of gentamicin, sisomicin, tobramycin and amikacin (BB-K8) against Pseudomonas sp.
    Dzierzanowska D
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):749-56. PubMed ID: 612299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Proposed use of a technic based on bioluminescence for determination of the minimal inhibiting concentration (MIC)].
    Crovatto M; Chiaradia V; Ius A; De Paoli P; Santini G; Grattoni E
    Quad Sclavo Diagn; 1981 Sep; 17(3):394-404. PubMed ID: 7045962
    [No Abstract]   [Full Text] [Related]  

  • 49. Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin.
    Hull R; Klinger JD; Moody EE
    J Gen Microbiol; 1976 Jun; 94(2):389-94. PubMed ID: 781182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
    Gerding DN; Larson TA
    Am J Med; 1985 Jul; 79(1A):1-7. PubMed ID: 4025364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative histophotometry analysing significant inductive and alterative effects of aminoglycoside application (gentamicin, tobramycin, amikacin) upon tubular kidney proteins.
    Heinert G; Wyrobnik J; Scherberich J; Mondorf W; Weber W
    Urol Int; 1982; 37(4):221-35. PubMed ID: 6182668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.
    Houang ET; McKay-Ferguson E
    Lancet; 1976 Feb; 1(7956):423-4. PubMed ID: 55682
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 54. [Distribution of aminoside resistance in 430 strains of gram-negative bacilli in a hospital environment. Value of amikacine].
    Le Noc P; Croizé J
    Sem Hop Ther; 1977; 53(7-8):378-83. PubMed ID: 244369
    [No Abstract]   [Full Text] [Related]  

  • 55. Patterns and mechanisms of antibiotic resistance.
    Murray BE; Moellering RC
    Med Clin North Am; 1978 Sep; 62(5):899-923. PubMed ID: 366296
    [No Abstract]   [Full Text] [Related]  

  • 56. Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium.
    Vanhoof R; Hubrechts JM; Nyssen HJ; Roebben E
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):183-5. PubMed ID: 3134209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The new aminoglycoside antibiotics.
    Fields BT
    J Ark Med Soc; 1976 Aug; 73(3):141-4. PubMed ID: 134018
    [No Abstract]   [Full Text] [Related]  

  • 58. A rapid chemical assay for gentamicin.
    Smith DH; Van Otto B; Smith AL
    N Engl J Med; 1972 Mar; 286(11):583-6. PubMed ID: 4550890
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
    Federspil P; Schätzle W; Tiesler E
    J Infect Dis; 1976 Aug; 134 Suppl():S200-5. PubMed ID: 972282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic activity in vitro of the new cephalosporin antibiotic HR 810 with gentamicin and amikacin against multiresistant pathogens.
    Seibert G; Limbert M; Klesel N
    J Antibiot (Tokyo); 1984 Aug; 37(8):929-30. PubMed ID: 6480508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.